GALT icon

Galectin Therapeutics

78 hedge funds and large institutions have $28.8M invested in Galectin Therapeutics in 2019 Q4 according to their latest regulatory filings, with 8 funds opening new positions, 25 increasing their positions, 10 reducing their positions, and 10 closing their positions.

New
Increased
Maintained
Reduced
Closed

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

more ownership

Funds ownership:

less funds holding

Funds holding:

less capital invested

Capital invested by funds: $ → $

20% less first-time investments, than exits

New positions opened: 8 | Existing positions closed: 10

48% less call options, than puts

Call options by funds: $453K | Put options by funds: $865K

Holders
78
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$453K
Puts
$865K
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
1
$7.39M
2
$5.25M
3
$2.4M
4
$2.29M
5
$1.92M
6
$1.56M
7
$1.4M
8
$545K
9
$472K
10
$468K
11
$327K
12
$307K
13
$265K
14
$258K
15
$255K
16
$227K
17
$194K
18
$179K
19
$174K
20
$163K
21
$157K
22
$147K
23
$126K
24
$119K
25
$115K